Oncology Clinical Trials and Drug Development are central to advancing cancer treatment and improving patient outcomes. Clinical trials are carefully designed research studies that test the safety, effectiveness, and potential side effects of new therapies, including chemotherapy, immunotherapy, targeted agents, and combination treatments. These trials progress through multiple phases to evaluate dosage, response, and long-term benefits. Drug development in oncology involves identifying promising molecules, understanding cancer biology, and designing therapies that target specific genetic or molecular abnormalities in tumors. Precision medicine and biomarker-driven approaches have transformed how drugs are created and tested. Participation in clinical trials not only offers patients access to innovative treatments but also contributes to global cancer research. Together, these efforts drive innovation, refine care standards, and pave the way for more effective, personalized cancer therapies.